查詢結果分析
相關文獻
- 一例多發性頭頸癌之診斷與治療--病例報告
- Giant Condyloma Acuminatum (Buschke-Loewenstein Tumor) of the Anorectum
- 利用核仁組成區嗜銀蛋白染色,以及增殖細胞核抗原、第四型膠原蛋白及板層素之免疫組織化學染色比較口腔疣狀上皮增生、疣狀癌與鱗狀細胞癌之差異
- 軟侸的類基底鱗狀細胞癌--病例報告
- 利用鐳射流體細胞儀回溯研究口腔鱗狀細胞癌之去氧核糖核酸套數
- 甲狀腺鱗狀細胞癌--病例報告
- Interleukin-1 β in Oral Submucous Fibrosis, Verrucous Hyperplasia and Squamous Cell Carcinoma Tissues
- 後臼齒三角區鱗狀細胞癌之外科治療考慮--回溯性研究
- 疣樣表皮發育不良--病例報告
- 口腔黏膜疣狀增生之臨床分析
頁籤選單縮合
題 名 | 一例多發性頭頸癌之診斷與治療--病例報告=Diagnosis and Treatment for Multiple Head and Neck Cancers--A Case Report |
---|---|
作 者 | 黃怡嘉; 張起華; 蔣維凡; | 書刊名 | 臺灣口腔顎面外科學會雜誌 |
卷 期 | 25:4 2014.12[民103.12] |
頁 次 | 頁276-287 |
分類號 | 416.21 |
關鍵詞 | 鱗狀細胞癌; 疣狀癌; 甲狀腺乳突狀癌; 增生性疣狀白斑症; 口腔黏膜下層纖維化症; 潛伏性轉移; Invasive carcinoma; Verrucous carcinoma; Proliferation verrucous leukoplakia; Oral submucous fibrosis; Thyroid cancer; Occult metastasis; |
語 文 | 中文(Chinese) |
中文摘要 | 增生性疣狀白斑症與口腔黏膜下層纖維化症屬於容易惡性轉變為疣狀癌或侵襲癌的高風險癌症前期疾病;甲狀腺癌是常見的頭頸癌之一,在罹癌初期常無明顯症狀,且不易察覺其潛伏性轉移。本報告提出一例59歲男性診斷為合併多發性口腔癌、多發性疣狀白斑症、口腔黏膜下層纖維化症與甲狀腺癌,接受手術切除病灶與同側頸部淋巴結廓清術的檢體中,發現二顆淋巴結遭受鱗狀細胞癌的轉移性侵犯,另有一顆第IIa區淋巴結是受到潛伏性甲狀腺乳突狀癌的轉移。病人於術後先接受同步放射線與化學藥物的輔助治療。一年後因甲狀腺仍有殘存腫瘤,病人接受甲狀腺近全切除手術和頸部淋巴廓清術,術後接受完整放射性碘131治療。在相關頭頸癌治療完成二年後,無任何腫瘤復發跡象。本文將就本病例診斷與治療過程進行報告與心得分享。 |
英文摘要 | Proliferative verrucous leukoplakia (PVL) and oral submucous fibrosis (OSF) are potentially malignant disorders that tend to transform to verrucous carcinoma and invasive carcinoma, Thyroid cancer that is a common cancer in head and neck region, is usually hard to detectable in the early stage, This report presents a 59-year-old man who had invasive carcinoma, verrucous carcinoma, OSF and PVL who underwent tumor ablation and ipsilateral cervical lymph node dissection, In the specimen, two cervical lymph nodes were invaded by metastatic carcinoma and one level IIa lymph node was metastasized by papillary thyroid carcinoma, According to the AJCC treatment guideline, the patient received adjuvant concurrent radiation therapy and chemotherapy, In the next year, the patient underwent subtotal thyroidectomy, neck dissection and radioactive iodine 131 treatment because the residual tumor of thyroid In the third year after the courses of cancer treatment, there was no evidence of tumor recurrence in the clinical and image follow up. |
本系統中英文摘要資訊取自各篇刊載內容。